Peripheral artery disease. Part 2: medical and endovascular treatment. - Wikidata - wikimedia - TriplyDB

Peripheral artery disease. Part 2: medical and endovascular treatment.

Peripheral artery disease. Part 2: medical and endovascular treatment.

http://www.wikidata.org/entity/Q37889106

about

MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1 Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation.Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study.Nanomedical Theranostics in Cardiovascular Disease.Fucoidan Stimulates Monocyte Migration via ERK/p38 Signaling Pathways and MMP9 Secretion.Hypoxia-induced angiogenesis: good and evil Stent revascularization versus bypass surgery for peripheral artery disease in type 2 diabetic patients - an instrumental variable analysis.Multimodality imaging approach for serial assessment of regional changes in lower extremity arteriogenesis and tissue perfusion in a porcine model of peripheral arterial disease.O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.Syndecan-4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes.Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

P2860

Q28534986-7D2A36FB-7B3D-47A6-899A-C9045417A4AD Q30300196-D195A5F5-9C3B-47A2-A4CB-2DDCF7073E8B Q30571370-F562E25B-A97F-41E5-BD14-DB25435036BA Q35678224-1F1AB32D-0339-43B8-9F69-45CC6764959B Q35681183-479F9F95-C4DC-476A-A625-29EDD94037D2 Q35890701-CBE82F47-5CDE-4733-8A74-5100CB76619D Q36137705-EEE092B0-0D19-49A1-85A5-F85A2971AFA9 Q37421609-A8DE017A-A7EB-4B6C-BA2F-7FE4C0597195 Q37594559-1A89B2D8-A889-4E9D-B2BC-FD18BE8C4B7E Q39456761-9CD8388F-D2C1-4372-8281-673FA66351BD Q41423118-AEB219FD-81F0-44DB-8CB0-569015E64D0C Q48247913-F03265CA-8B5D-49B7-9CC3-5637F36787B0

P2860

Peripheral artery disease. Part 2: medical and endovascular treatment.

http://www.wikidata.org/entity/Q37889106

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Peripheral artery disease. Part 2: medical and endovascular treatment.

@en

Peripheral artery disease. Part 2: medical and endovascular treatment.

@nl

type

label

Peripheral artery disease. Part 2: medical and endovascular treatment.

@en

Peripheral artery disease. Part 2: medical and endovascular treatment.

@nl

prefLabel

Peripheral artery disease. Part 2: medical and endovascular treatment.

@en

Peripheral artery disease. Part 2: medical and endovascular treatment.

@nl

P1433

Q37889106-C2563A85-B218-4DEF-BE38-35CFB7DE1564

P1476

Q37889106-864CFA8C-B646-45E8-A7B0-E8D78E09E39D

P2093

Q37889106-1B4617B9-CC57-4004-9037-15665AE561C2

Q37889106-2F9A1EEF-AA6D-4C36-A555-0312A294FD08

Q37889106-38470D73-66CD-4089-B7A0-0A9BCD403C89

Q37889106-63F8394E-9851-41D0-B506-8E680B86A3FD

P2860

Q37889106-006710CC-B96A-4898-8F66-9955CCCDD0E2

Q37889106-02F50356-66C7-48C7-8892-278F9CD81D30

Q37889106-08F9EF00-591E-4B97-8F5C-7B6AF4CDCE61

Q37889106-111F3C5B-8EAC-492E-993A-F5FA389C3D56

Q37889106-194DB387-095C-4E37-AEE9-35A03A28D17A

Q37889106-19D3A9D8-0C51-4453-AB75-0600CD4DDF63

Q37889106-1A2337B1-B6E7-4B4D-BF5B-ED40B7EF1EED

Q37889106-220BD2EF-60D5-4A8D-92DC-A17D606FF3DE

Q37889106-24EA232B-812F-45F1-9917-A9CFD8D064C8

Q37889106-272D570A-80D2-4F6C-AD17-B3860A752365

P304

Q37889106-06C07DEA-4A81-464A-B396-FED7CDC75D5A

P31

Q37889106-FC44B34D-2FB9-4A6B-BAC9-F6AE4FB482F3

P356

Q37889106-455739BA-8525-40BB-B14D-6DFC2E803E4C

P407

Q37889106-6F9BE467-DF10-4C37-95C7-A4DE698A7DBD

P433

Q37889106-F91B4D3E-B72A-4A13-ABAB-20348EC60953

P478

Q37889106-225F98FE-7246-4EB7-B173-DF274238D045

P577

Q37889106-09746969-A357-453B-8591-6700487723BC

P698

Q37889106-7641C3D0-8647-42B5-AC8A-9AD96F48EC22

P356

NRCARDIO.2011.81

P1433

Nature Reviews Cardiology

P1476

Peripheral artery disease. Part 2: medical and endovascular treatment.

@en

P2093

Jeffrey W Olin

http://www.w3.org/2001/XMLSchema#string

Joe F Lau

http://www.w3.org/2001/XMLSchema#string

Kenneth Rosenfield

http://www.w3.org/2001/XMLSchema#string

Mitchell D Weinberg

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Peripheral arterial disease in people with diabetes

Stent placement for chronic iliac arterial occlusive disease: the results of 10 years experience in a single institution

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

P304

429-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2011.81

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21670746

http://www.w3.org/2001/XMLSchema#string